TCAF vs BOUT5YTCAFTCAFAvsBBOUTBOUTT. Rowe Capital Appreciation Equity ETF · $7.6BCapForce IBD Breakout Opportunities ETF · $14MReturns · dividends in+20.2%3 years · per year$17,365 · $13,629+10.9%[…]5 years · per year[…] · $10,937+1.8%Cost and income0.31%Expense ratio$31 · $80 on $10k · lower wins0.80%0.44%12-mo yield$44 · $32 on $10k
$10,000 in TCAF, BOUT, CGBL5Y$10k startBOUT $10.7kNov 2021Nov 2026End-of-day Nov 12, 2026 · growth of $10,000, dividends reinvested · from each fund’s start inside the window
Overlap: TCAF, BOUT, CGBLToday8.1%most shared, TCAF and CGBLTCAFBOUTCGBLTCAF—0.0%8.1%BOUT0.0%—0.0%CGBL8.1%0.0%—End-of-day Nov 12, 2026 · share held in common · outlined: the pair in versus
TCAF vs BOUT5YATCAFT. Rowe Capital Appreciation Equity[…]vsBOUTBCapForce IBD Breakout Opportunities$10,937MeasureTCAFBOUTFee0.31%0.80%Cost on $10k a year$31$80Yield0.44%0.32%5 years, per year[…]+1.8%3 years, per year+20.2%+10.9%Worst drop · 1Y−10.8%−20.8%Volatility · 1Y13.1%
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1BBOUTCapForce IBD Breakout Opportunities ETFReadDesk0.80%0.32%+0.3%+9.0%+4.8%+10.9%+1.8%−20.8%$14M2ATCAFT. Rowe Capital Appreciation Equity ETFReadDesk0.31%0.44%+0.9%+13.8%+13.0%+20.2%new−10.8%$7.6B3CGBLCapital Group Core Balanced ETFReadDesk0.33%1.94%+0.4%+6.8%+9.0%+16.2%new−7.9%$8.1BEnd-of-day Nov 12, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1BBOUTCapForce IBD Breakout Opportunities ETFReadDesk0.80%0.32%+0.3%+9.0%+4.8%+10.9%+1.8%−20.8%$14M2ATCAFT. Rowe Capital Appreciation Equity ETFReadDesk0.31%0.44%+0.9%+13.8%+13.0%+20.2%new−10.8%$7.6B3CGBLCapital Group Core Balanced ETFReadDesk0.33%1.94%+0.4%+6.8%+9.0%+16.2%new−7.9%$8.1BEnd-of-day Nov 12, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
SCHD vs VIGYTDSchwabSCHDSA+34.6%vsBVVIGVanguard+16.0%Jan 1Nov 12+34.6%+16.0%+34.6%Year to date+16.0%2.9%Yield1.4%$123BAssets$109B2–0SCHD winsEnd-of-day Nov 12, 2026
JEPQ vs JEPIYTDJ.P. MorganJEPQJMA+8.1%vsBJMJEPIJ.P. Morgan+8.6%Jan 1Nov 12+8.1%+8.6%+8.1%Year to date+8.6%12.2%Yield7.8%$41.8BAssets$46.8B1–1levelEnd-of-day Nov 12, 2026
SPYM vs SPYYTDSPDRSPYMSA+12.4%vsBSSPYSPDR+12.3%Jan 1Nov 12+12.4%+12.3%+12.4%Year to date+12.3%1.0%Yield1.0%$183BAssets$793B1–0SPYM winsEnd-of-day Nov 12, 2026
Overlap: TCAF, BOUT, CGBLToday8.1%most shared, TCAF and CGBLTCAFBOUTCGBLTCAF—0.0%8.1%BOUT0.0%—0.0%CGBL8.1%0.0%—End-of-day Nov 12, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$161most kept, CGBLCGBL$194 − $33 = $161TCAF$44 − $31 = $13BOUT$32 − $80 = −$48KeptFeeEnd-of-day Nov 12, 2026 · yield in dollars minus the fee